Abdelkareem Alhyari

Hamad Medical Corporation

Papers

1

Total Citations

2

H-Index

1

About

Dr. Abdelkareem Alhyari is a dedicated clinical researcher whose work centers on the diagnosis and characterization of rare genitourinary malignancies, with a particular focus on renal cell carcinoma (RCC) subtypes. His major contribution lies in advancing the clinical understanding of tubulocystic renal cell carcinoma, a rare tumor only formally recognized by the World Health Organization in 2016. In his most cited case report, Dr. Alhyari documents the incidental discovery of this indolent neoplasm in a 35-year-old male, providing valuable insights into its typically low metastatic potential and favorable prognosis. This work, published in 2024 and already garnering 2 citations, serves as an important reference for pathologists and urologists encountering this uncommon entity. By highlighting the diagnostic challenges and clinical behavior of tubulocystic RCC, Dr. Alhyari’s research contributes to the growing body of literature that helps refine treatment strategies and reduce unnecessary interventions for patients with these rare tumors. His findings underscore the importance of accurate histopathological classification in guiding patient management and prognosis.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Tubulocystic renal cell carcinoma: A case report of rare tumor
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Hamad Medical Corporation

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago